Concepedia

Irwin Hollander

IH

Statistics

Publications

42

Citations

3K

H-Index

30

Active since

1979

Affiliations

Pearl River Community College(Current)

NOAA Chemical Sciences Laboratory

Women's Health Research Institute

University of Amsterdam

University of British Columbia

Irwin Hollander is an author at Pearl River Community College specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1979–2011

42

Publications

42

Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia

Philip R. Hamann, Lois M. Hinman, Irwin Hollander et al. · Bioconjugate Chemistry · 2001 · 587 citations

, , +17

Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound <b>26</b> (PKI-587), a Highly Efficacious Dual Inhibitor

Aranapakam M. Venkatesan, Christoph M. Dehnhardt, Efren Delos Santos et al. · Journal of Medicinal Chemistry · 2010 · 212 citations · Full text

, , +14

Adenomyoepithelioma of the Breast

Jeffrey H. Loose, Arthur S. Patchefsky, Irwin Hollander et al. · The American Journal of Surgical Pathology · 1992 · 184 citations

, , +12

Antitumor Efficacy of PKI-587, a Highly Potent Dual PI3K/mTOR Kinase Inhibitor

Robert Mallon, Larry Feldberg, Judy Lucas et al. · Clinical Cancer Research · 2011 · 170 citations · Full text

, , +17

Liphagal, a Selective Inhibitor of PI3 Kinase α Isolated from the Sponge <i>Aka </i><i>c</i><i>oralliphaga</i>:  Structure Elucidation and Biomimetic Synthesis

Frédéric Marion, David E. Williams, Brian O. Patrick et al. · Organic Letters · 2005 · 155 citations

, , +16

1–5 of 42